ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® GU 2024 Insights: "EMBARK Study - Enzalutamide Monotherapy Compared to Leuprolide Alone in High-Risk Biochemically Recurrent Prostate Cancer"
By
ecancer
FEATURING
Neal Shore
By
ecancer
FEATURING
Neal Shore
Login to view comments.
Click here to Login
